The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Graphical Depiction of Longitudinal Study Designs in Health Care Databases
Open accessAbstract
Pharmacoepidemiologic and pharmacoeconomic analysis of health care databases has become a vital source of evidence to support health care decision making and efficient management of health care organizations. However, decision makers often consider studies done in nonrandomized health care databases more difficult to review than randomized trials because many design choices need to be considered. This is perceived as an important barrier to decision making about the effectiveness and safety of medical products. Design flaws in longitudinal database studies are avoidable but can be unintentionally obscured in the convoluted prose of methods sections, which often lack specificity. We propose a simple framework of graphical representation that visualizes study design implementations in a comprehensive, unambiguous, and intuitive way; contains a level of detail that enables reproduction of key study design variables; and uses standardized structure and terminology to simplify review and communication to a broad audience of decision makers. Visualization of design details will make database studies more reproducible, quicker to review, and easier to communicate to a broad audience of decision makers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events
Maclure, M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115853 · Cited by 2,327
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,708
Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
A combined comorbidity score predicted mortality in elderly patients better than existing scores
Gagne, J. J., Glynn, R. J., Avorn, J., Levin, R., & Schneeweiss, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.004 · Cited by 995
Hernán, M. A., Alonso, A., Logan, R., Grodstein, F., Michels, K. B., Willett, W. C., Manson, J. E., & Robins, J. M. (2008) · Epidemiology · doi:10.1097/ede.0b013e3181875e61 · Cited by 818
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719
Immortal time bias in observational studies of drug effects
Suissa, S. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1357 · Cited by 584
Langan, S. M., Schmidt, S. A., Wing, K., Ehrenstein, V., Nicholls, S. G., Filion, K. B., Klungel, O., Petersen, I., Sorensen, H. T., Dixon, W. G., et al. (2018) · BMJ · doi:10.1136/bmj.k3532 · Cited by 550
Self-citationBeyond the intention-to-treat in comparative effectiveness research
Hernán, M. A., & Hernández-Díaz, S. (2012) · Clinical Trials · doi:10.1177/1740774511420743 · Cited by 528
(2020) · Clinical Epidemiology · doi:10.2147/clep · Cited by 467
Berger, M. L., Sox, H., Willke, R. J., Brixner, D. L., Eichler, H., Goettsch, W., Madigan, D., Makady, A., Schneeweiss, S., Tarricone, R., et al. (2017) · Value in Health · doi:10.1016/j.jval.2017.08.3019 · Cited by 456
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Berger, M. L., Sox, H., Willke, R. J., Brixner, D. L., Eichler, H., Goettsch, W., Madigan, D., Makady, A., Schneeweiss, S., Tarricone, R., et al. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4297 · Cited by 344
Self-citationHallas, J. (1996) · Epidemiology · doi:10.1097/00001648-199609000-00005 · Cited by 289
Azoulay, L., Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., & Suissa, S. (2012) · BMJ · doi:10.1136/bmj.e3645 · Cited by 270
ROTHMAN, K. J. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113189 · Cited by 264
Self-citationA basic study design for expedited safety signal evaluation based on electronic healthcare data
Schneeweiss, S. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1926 · Cited by 255
Self-citationEvidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
Yola, M., & Lucien, A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90170-8 · Cited by 253
Schneeweiss, S., Patrick, A. R., Stürmer, T., Brookhart, M. A., Avorn, J., Maclure, M., Rothman, K. J., & Glynn, R. J. (2007) · Medical Care · doi:10.1097/mlr.0b013e318070c08e · Cited by 253
Self-citationThe FDA's sentinel initiative—A comprehensive approach to medical product surveillance
Ball, R., Robb, M., Anderson, S., & Dal Pan, G. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.320 · Cited by 248
Self-citationDesign considerations, architecture, and use of the Mini‐Sentinel distributed data system
Curtis, L. H., Weiner, M. G., Boudreau, D. M., Cooper, W. O., Daniel, G. W., Nair, V. P., Raebel, M. A., Beaulieu, N. U., Rosofsky, R., Woodworth, T. S., et al. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2336 · Cited by 224
Self-citationRassen, J. A., Choudhry, N. K., Avorn, J., & Schneeweiss, S. (2009) · Circulation · doi:10.1161/circulationaha.109.873497 · Cited by 220
Self-citationHemkens, L. G., Contopoulos-Ioannidis, D. G., & Ioannidis, J. P. A. (2016) · BMJ · doi:10.1136/bmj.i493 · Cited by 220
Toh, S., Reichman, M. E., Houstoun, M., Ross Southworth, M., Ding, X., Hernandez, A. F., Levenson, M., Li, L., McCloskey, C., Shoaibi, A., et al. (2012) · Archives of Internal Medicine · doi:10.1001/2013.jamainternmed.34 · Cited by 215
Makady, A., Ham, R. T., de Boer, A., Hillege, H., Klungel, O., & Goettsch, W. (2017) · Value in Health · doi:10.1016/j.jval.2016.12.003 · Cited by 206
Self-citationKim, S. C., Solomon, D. H., Rogers, J. R., Gale, S., Klearman, M., Sarsour, K., & Schneeweiss, S. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40084 · Cited by 195
Self-citationImmeasurable Time Bias in Observational Studies of Drug Effects on Mortality
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn135 · Cited by 191
Wang, S. V., Schneeweiss, S., Berger, M. L., Brown, J., de Vries, F., Douglas, I., Gagne, J. J., Gini, R., Klungel, O., Mullins, C. D., et al. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4295 · Cited by 182
Self-citationWhen should case‐only designs be used for safety monitoring of medical products?
Maclure, M., FIREMAN, B. H., Nelson, J. C., Hua, W., Shoaibi, A., Paredes, A., & Madigan, D. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2330 · Cited by 159
Jena, A. B., Goldman, D. P., Weaver, L., & Karaca‐Mandic, P. (2014) · BMJ · doi:10.1136/bmj.g1393 · Cited by 156
Pharmacoepidemiology and Drug Safety
Boshier, A., Shakir, S. A. W., Telfer, P. T., Behr, E., Pakrashi, T., & Camm, A. J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(issn)1099-1557 · Cited by 136
Causation of Bias: The Episcope
Maclure, M., & Schneeweiß, S. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00019 · Cited by 128
Wang, S. V., Schneeweiß, S., Berger, M. L., Brown, J. S., de Vries, F., Douglas, I., Gagne, J. J., Gini, R., Klungel, O. H., Mullins, C. D., et al. (2017) · Value in Health · doi:10.1016/j.jval.2017.08.3018 · Cited by 118
Self-citationAutomated data-adaptive analytics for electronic healthcare data to study causal treatment effects
Schneeweiß, S. (2018) · Clinical Epidemiology · doi:10.2147/clep.s166545 · Cited by 85
Brunelli, S. M., Gagne, J. J., Huybrechts, K. F., Wang, S. V., Patrick, A. R., Rothman, K. J., & Seeger, J. D. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3434 · Cited by 79
Self-citationBaker, M. A., Lieu, T. A., Li, L., Hua, W., Qiang, Y., Kawai, A. T., FIREMAN, B. H., Martin, D., & Nguyen, M. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu322 · Cited by 76
Using Design Thinking to Differentiate Useful From Misleading Evidence in Observational Research
Goodman, S. N., Schneeweiß, S., & Baiocchi, M. (2017) · JAMA · doi:10.1001/jama.2016.19970 · Cited by 75
Malone, D. C., Brown, M., Hurwitz, J. T., Peters, L., & Graff, J. S. (2017) · Value in Health · doi:10.1016/j.jval.2017.08.3013 · Cited by 74
Douglas, I. J., Langham, J., Bhaskaran, K., Brauer, R., & Smeeth, L. (2013) · BMJ · doi:10.1136/bmj.f1936 · Cited by 73
Counterpoint: The Treatment Decision Design
Brookhart, M. A. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv214 · Cited by 72
Matcho, A., Ryan, P. B., Fife, D., & Reich, C. (2014) · Drug Safety · doi:10.1007/s40264-014-0214-3 · Cited by 71
Gini, R., Schuemie, M. J., Brown, J. S., Ryan, P. B., Vacchi, E., Coppola, M., Cazzola, W., Coloma, P. M., Berni, R., Diallo, G., et al. (2016) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1189 · Cited by 68
Self-citationEffect of Statin Use on Acute Kidney Injury Risk Following Coronary Artery Bypass Grafting
Layton, J. B., Kshirsagar, A. V., Simpson, R. J., Pate, V., Funk, M. J., Stürmer, T., & Brookhart, M. A. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.047 · Cited by 62
Effects of expanding the look‐back period to all available data in the assessment of covariates
Nakasian, S. S., Rassen, J. A., & Franklin, J. M. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4210 · Cited by 43
Self-citationGruber, S., Chakravarty, A. G., Heckbert, S. R., Levenson, M. S., Martin, D., Nelson, J. C., Psaty, B. M., Pinheiro, S. P., Reich, C., Toh, S., et al. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4065 · Cited by 29
Utilizing Medicare claims data for real‐time drug safety evaluations: is it feasible?,
Hartzema, A. G., Racoosin, J. A., MaCurdy, T. E., Gibbs, J. M., & Kelman, J. A. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2143 · Cited by 26
Bykov, K., Schneeweiß, S., Glynn, R. J., Mittleman, M. A., Bates, D. W., & Gagne, J. J. (2017) · Drug Safety · doi:10.1007/s40264-017-0556-8 · Cited by 15
Methods for addressing “innocent bystanders” when evaluating safety of concomitant vaccines
Wang, S. V., Abdurrob, A., Spoendlin, J., Lewis, E. M., Newcomer, S. R., FIREMAN, B. H., Daley, M. F., Glanz, J. M., Duffy, J., Weintraub, E., et al. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4399 · Cited by 5
Self-citation
Cited by
Barlowe, T. S., Anderson, C., Sandler, R. S., Subramaniam, D., Muratore, A., Buse, J. B., Gouker, L. N., Majithia, R. T., Shaheen, N. J., Stürmer, T., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.04.038 · Cited by 55
Metadata
- Authors
- Schneeweiss, S., Rassen, J. A., Brown, J. S., Rothman, K. J., Happe, L., Arlett, P., Dal Pan, G., Goettsch, W., Murk, W., & Wang, S. V.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2019-03-19
- Volume
- 170
- Issue
- 6
- Pages
- 398-406
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2921045850
- Cited by
- 275
- References
- 49
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.